Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Levothyroxine sodium 100microgram tablets
0602010V0AABZBZ
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1,330,735 |
|
Levothyroxine sodium 50microgram tablets
0602010V0AABXBX
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1,199,790 |
|
Levothyroxine sodium 25microgram tablets
0602010V0AABWBW
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 980,132 |
|
Levothyroxine sodium 75microgram tablets
0602010V0AABYBY
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 306,126 |
|
Levothyroxine sodium 12.5microgram tablets
0602010V0AAGHGH
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 38,633 |
|
Levothyroxine sodium 50micrograms/5ml soln sugar free
0602010V0AAGAGA
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 9,051 |
|
Levothyroxine sodium 100micrograms/5ml soln sugar free
0602010V0AAGBGB
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 5,216 |
|
Levothyroxine sodium 25micrograms/5ml soln sugar free
0602010V0AAFZFZ
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 3,978 |
|
Levothyroxine sodium 125micrograms/5ml soln sugar free
0602010V0AAGIGI
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 849 |
|
Levothyroxine sodium 75micrograms/5ml soln sugar free
0602010V0AAGKGK
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 346 |
|
Levothyroxine sodium 25microgram capsules
0602010V0AAAGAG
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 331 |
|
Levothyroxine sodium 50microgram capsules
0602010V0AAAFAF
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 260 |
|
Levothyroxine sodium 100microgram capsules
0602010V0AACMCM
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 185 |
|
Levothyroxine sodium 50micrograms/5ml oral liquid
0602010V0AACWCW
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 37 |
|
Levothyroxine sodium 100micrograms/5ml oral liquid
0602010V0AACXCX
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 16 |
|
Levothyroxine sodium 25micrograms/5ml oral liquid
0602010V0AACZCZ
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 12 |
|
Levothyroxine sodium 250micrograms/5ml oral liquid
0602010V0AADCDC
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 5 |
|
Levothyroxine sodium 37.5micrograms/5ml oral liquid
0602010V0AADBDB
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 4 |
|
Levothyroxine sodium 125micrograms/5ml oral liquid
0602010V0AACYCY
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 2 |
|
Levothyroxine sodium 75microgram oral powder sachets
0602010V0AACCCC
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 2 |
|
Levothyroxine sodium 10microgram capsules
0602010V0AACICI
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1 |
|
Levothyroxine sodium 12.5microgram capsules
0602010V0AABMBM
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1 |
|
Levothyroxine sodium 2.5mg/5ml oral liquid
0602010V0AAFBFB
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1 |
|
Levothyroxine sodium 200micrograms inj vials
0602010V0AAFWFW
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1 |
|
Levothyroxine sodium 100microgram oral powder sachets
0602010V0AACQCQ
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.